JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

✍ Scribed by Rumi, E.; Pietra, D.; Ferretti, V.; Klampfl, T.; Harutyunyan, A. S.; Milosevic, J. D.; Them, N. C. C.; Berg, T.; Elena, C.; Casetti, I. C.; Milanesi, C.; Sant'Antonio, E.; Bellini, M.; Fugazza, E.; Renna, M. C.; Boveri, E.; Astori, C.; Pascutto, C.; Kralovics, R.; Cazzola, M.

• Book ID: 121478383
• Publisher: American Society of Hematology
• Year: 2014
• Tongue: English
• Weight: 520 KB
• Volume: 123
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2013-11-539098